Real‐world evaluation of a population‐based vaginal self‐sampling program for cervical cancer prevention in Region Skåne, Sweden
Acta Obstetricia et Gynecologica Scandinavica · 2026
DOI: 10.1111/aogs.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2026. Verfasst von Caroline Hellsten und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Vaginal Smears, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: South Swedish Regional Funds.
Abstract (Originalsprache)
Introduction
Cervical cancer represents a significant public health challenge worldwide. To improve screening accessibility and participation, we implemented vaginal human papilloma virus (HPV) self‐sampling as part of an organized cervical cancer prevention strategy. This study aimed to evaluate the implementation and outcomes of the self‐sampling program in a real‐world setting. Material and Methods Between September 1, 2021 and December 31, 2024, a total of 557 976 vaginal self‐sampling kits were distributed. Follow‐up with cervical sampling continued through April 2025. Data were collected using the Laboratory Information Management System (LIMS) and the Melior Journal system.
Results
Of the distributed kits, 208 386 were returned, yielding an adherence rate of 37% (208 386/557 976). Among the valid samples, 19% (39 697/204 763) tested positive for HPV. Follow‐up adherence among HPV‐positive women was 81% (32 305/39 697), defined as attendance at follow‐up clinics by the end of the fourth subsequent calendar month. Cervical samples were HPV‐positive in 39% (12 495/32 305) and HPV16 or HPV18/45 were detected in 2157 cases (17%). Cytological analysis identified high‐grade cervical dysplasia in 759 women (6.1%, 759/12 505) and histopathology confirmed its presence in 980 cases (13%, 980/7641). Cervical cancer was diagnosed in 32 cervical biopsies (0.4%, 32/7647).
Conclusions
The vaginal self‐sampling program was effective in detecting HPV. Its capacity to identify HPV types and significant cytological abnormalities underscores its potential for facilitating early detection, enhancing screening coverage and timely clinical intervention, thereby reducing the incidence of cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden.
- Department of Clinical Science Lund, Lund University, Lund, Sweden.
- Clinical Microbiology, Infection Prevention and Control, Office for Medical Services Region Skåne, and Translational Medicine, Lund University, Lund, Sweden.
- Department of Obstetrics and Gynecology, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
ORCID-Profile: Caroline Hellsten, Ola Forslund
Förderung
- South Swedish Regional Funds
Zitieren
APA
Hellsten, C., Forslund, O., & Borgfeldt, C. (2026). Real‐world evaluation of a population‐based vaginal self‐sampling program for cervical cancer prevention in Region Skåne, Sweden. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70206
Vancouver
Hellsten C, Forslund O, Borgfeldt C. Real‐world evaluation of a population‐based vaginal self‐sampling program for cervical cancer prevention in Region Skåne, Sweden. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70206
BibTeX
@article{Hellsten2026,
author = {Hellsten, Caroline and Forslund, Ola and Borgfeldt, Christer},
title = {Real‐world evaluation of a population‐based vaginal self‐sampling program for cervical cancer prevention in Region Skåne, Sweden},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
doi = {10.1111/aogs.70206}
}
EUVIMED